Post

New research · Ophthalmology
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 17h
Cohort studyCanadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2026

International validation of a staging system for ciliary body and choroidal melanomas using estimated tumour volume.

Sacha Nahon-Estève, Jean-Pierre Caujolle, Célia Maschi … Gustav Stålhammar
Read paper
OphthalmologyCohort study

New tumour-volume staging predicts uveal melanoma prognosis better than AJCC staging

International validation of a staging system for ciliary body and choroidal melanomas using estimated tumour volume.

Sacha Nahon-Estève … Gustav Stålhammar
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2026
Purpose

To validate a newly proposed anatomic staging system for choroidal and ciliary body melanoma, based on tumour volume estimated from routine clinical measurements, and compare its prognostic performance with the American Joint Committee on Cancer (AJCC) 8th edition classification.

Methods

A total of 5 410 consecutive patients diagnosed with choroidal and/or ciliary body melanoma at 6 European ocular oncology centres.

n = 5 410 consecutive patients
Results

new staging spots more high- and low-risk patients correctly than old system

1.42subdis
New classification
1.22subdis
AJCC 8th edition
More results

In competing risk regression, it produced a higher Wald statistic (761 vs 628) and a subdistribution hazard ratio of 1.42 versus 1.22.

Cox regression for melanoma-related mortality demonstrated higher hazard ratios, peaking at 24 for the new model compared with 13 for the AJCC classification.

More results

Cumulative incidence analyses revealed 15-year metastatic death rates ranging from 7% to 76% with the new system versus 11% to 69% with AJCC, widening the absolute range by 11 percentage points.

“
Conclusion · 1 of 2

This large international validation study demonstrates that the new volume-based classification provides more accurate prognostic stratification for choroidal and ciliary body melanoma.

Conclusion · 2 of 2

Its improved risk discrimination, using readily available clinical measurements, supports its applicability in clinical practice and potential utility for guiding follow-up and resource allocation.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving